Brimonidine tartrate and Timolol maleate
Brimonidine tartrate and Timolol maleate is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand names including Brimonidine tartrate and Timolol maleate, BRIMONIDINE TARTRATE AND TIMOLOL MALEATE. Available dosage forms: solution/ drops, solution.
Drug Details
- Generic Name
- Brimonidine tartrate and Timolol maleate
- Brand Names
- Brimonidine tartrate and Timolol maleate, BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
- Application Number
- ANDA201949
- Sponsor
- NorthStar RxLLC
- NDC Codes
- 2
- Dosage Forms
- SOLUTION/ DROPS, SOLUTION
- Routes
- OPHTHALMIC
- Active Ingredients
- BRIMONIDINE TARTRATE, TIMOLOL MALEATE
Indications and Usage
1 INDICATIONS & USAGE Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5% is an alpha-adrenergic receptor agonist with a beta-adrenergic receptor inhibitor indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP; the IOP-lowering of brimonidine tartrate/timolol maleate ophthalmic solution dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution dosed twice a day and 0.2% brimonidine tartrate ophthalmic solution dosed three times per day. Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution is an alpha-adrenergic receptor agonist with a beta-adrenergic receptor inhibitor indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP; the IOP-lowering of brimonidine tartrate/timolol maleate ophthalmic solution dosed twice a day was slightly less than that seen with the concomitant administration of timolol maleate ophthalmic solution, 0.5% dosed twice a day and brimonidine tartrate ophthalmic solution, 0.2% dosed three times per day.